Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Sex, male | 0.83 | 0.49–1.42 | 0.497 |  |  |  |
Age ≥ 65 years | 1.27 | 0.74–2.17 | 0.379 |  |  |  |
BMI ≥ 25 mg/kg2 | 1.51 | 0.79–2.86 | 0.212 |  |  |  |
eGFR < 60 mL/min/1.73 m2 | 1.44 | 0.78–2.64 | 0.243 |  |  |  |
Bevacizumab dose of 7.5 mg/kg | 1.22 | 0.71–2.08 | 0.473 |  |  |  |
Pre-existing hypertension | 1.86 | 1.09–3.19 | 0.023 | 1.60 | 0.92–2.77 | 0.096 |
Baseline SBP ≥ 140 mmHg | 1.75 | 0.94–3.27 | 0.079 |  |  |  |
Baseline DBP ≥ 90 mmHg | 1.94 | 0.92–4.12 | 0.083 |  |  |  |
Average SBP ≥ 140 mmHg within 3 months | 2.33 | 1.36–4.00 | 0.002 | 2.11 | 1.21–3.67 | 0.008 |
Average DBP ≥ 90 mmHg within 3 months | 1.79 | 0.90–3.56 | 0.097 |  |  |  |